Objectives: Hepatitis C virus (HCV) is an important viral agent ofhepatitis, cirrhosis and hepatocellular carcinoma. In our study, weaimed to determine the HCV genotype distribution among patientswith HCV who presented to our hospital in a city in the CentralAnatolia Region of Turkey.Materials and Methods: Results of 480 patients who were positivefor HCV RNA and whose serum samples were sent to our laboratoryfrom various inpatient and outpatient clinics of the hospital with apre-diagnosis of hepatitis C between January 2010 and May 2017were retrospectively screened. In HCV genotype determination,a commercially available kit (Ampliquality HCV-TS, AB Analitica®,Italy) based on Reverse Line Blot was used in accordance with themanufacturer’s recommendations. Genotype distributions wereanalyzed by years and by age. The first and only one test results ofthe same patients were evaluated.Results: Of the patients whose genotyping was made, 260(54.2%) were female and 220 (45.8%) were male. It was found that396 (82.6%) of 480 patients were with genotype 1b, 17 (3.5%) -genotype 1a, 15 (3.1%) - genotype 3a, 14 (2.9%) - genotype 1, 9(1.9%) - genotype 4, 8 (1.7%) - genotype 2, 6 (1.3%) - genotype2b, 5 (1.0%) - genotype 1a/1b, 4 (0.8%) - genotype 2a/2c, 3 (0.6%)- genotype 4a, 1 (0.2%) - genotype 3, 1 (0.2%) - genotype 5a and 1(0.2%) patient was with genotype 6.Conclusion: In chronic HCV patients admitted to our hospital,genotype 1b, which had the highest prevalence in our country, wasdetected with a rate of 82.6%. In addition, the presence of raregenotypes 5a and 6 in our country has been shown.